[Diagnosis, evaluation and follow-up of patients with prostatic cancer]
- PMID: 17553363
[Diagnosis, evaluation and follow-up of patients with prostatic cancer]
Abstract
The current diagnostic modalities for diagnosing and evaluating prostate cancer are described. DRE, PSA and TRUS are the three major cornerstones of the diagnostic approach and further evaluation includes bone scans. Lymphnode status can be evaluated only by lymphadenectomy, but is only of interest when curative treatment is considered. Follow-up after both curative intended treatment and hormonal treatment for advanced disease includes regular clinical checkups and evaluation of PSA status. Specific examinations may be considered depending on the symptoms and findings.
Similar articles
-
[Status of PSA determination for early detection of prostate carcinoma].Versicherungsmedizin. 1995 Jun 1;47(3):83-6. Versicherungsmedizin. 1995. PMID: 7541925 Review. German.
-
[Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. II. Rectal palpation, PSA, and transrectal echography].Arch Esp Urol. 1997 May;50(4):339-45. Arch Esp Urol. 1997. PMID: 9313042 Spanish.
-
[Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. I. PSA, PSA density, and predicted PSA].Arch Esp Urol. 1997 May;50(4):333-8. Arch Esp Urol. 1997. PMID: 9313041 Spanish.
-
Early diagnosis of prostate cancer in the Western Cape.S Afr Med J. 2001 Aug;91(8):679-84. S Afr Med J. 2001. PMID: 11584784
-
Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.Scand J Urol Nephrol Suppl. 1994;162:73-87; discussion 115-27. Scand J Urol Nephrol Suppl. 1994. PMID: 7529430 Review.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous